A patient with rheumatoid arthritis is experiencing increased joint pain, stiffness, and fatigue despite current treatment. Laboratory results show anemia and elevated C-reactive protein levels. Considering the nurse's assessment and the healthcare team's decision to adjust the treatment plan, which nursing intervention is most appropriate to address the patient's symptoms and improve her overall quality of life?

B) Educate the patient on the importance of stress management and gentle physical activity.

A) Encourage the patient to engage in high-intensity exercise to improve joint mobility.

B) Educate the patient on the importance of stress management and gentle physical activity.

C) Advise the patient to rest frequently and avoid any physical activity to prevent further joint damage.

D) Recommend the patient increase dietary iron intake to address anemia and disregard other symptoms.

A patient with rheumatoid arthritis is experiencing increased joint pain, stiffness, and fatigue despite current treatment. Her laboratory results indicate anemia and elevated CRP levels. What is the most appropriate nursing intervention to address her anemia?

A) Encourage the patient to increase her intake of red meat and leafy green vegetables.

B) Recommend the patient start taking an over-the-counter iron supplement without consulting her healthcare provider.

C) Advise the patient to increase her vitamin D intake to improve joint health.

D) Suggest the patient reduce her physical activity to conserve energy and reduce fatigue.

A patient with rheumatoid arthritis has shown partial improvement but continues to experience significant fatigue and hypertension. Considering her current clinical status, which intervention should the nurse prioritize to further optimize her treatment plan?

C) Collaborate with the healthcare provider to adjust antihypertensive medication.

A) Increase the dose of her current biologic DMARD.

B) Initiate a physical therapy program focusing on high-impact exercises.

C) Collaborate with the healthcare provider to adjust antihypertensive medication.

D) Encourage the patient to incorporate iron-rich foods and vitamin C into her diet.

A patient with rheumatoid arthritis reports slight improvement in joint pain and morning stiffness after recent treatment adjustments, but continues to experience significant fatigue and difficulty with prolonged physical activity. Her blood pressure is 148/95 mmHg, heart rate is 92 bpm, and she remains anemic with a hemoglobin level of 11.0 g/dL. The CRP level has decreased to 20 mg/L. What should be the nurse's priority intervention to address the patient's current condition?

C) Discuss with the healthcare team the possibility of optimizing her biologic DMARD dosage and addressing her anemia.

A) Educate the patient on increasing her DMARD dosage without consulting the physician.

B) Encourage the patient to engage in high-impact exercises to improve cardiovascular fitness.

C) Discuss with the healthcare team the possibility of optimizing her biologic DMARD dosage and addressing her anemia.

D) Advise the patient to monitor her blood pressure weekly and report significant changes.

A patient with rheumatoid arthritis and poorly controlled hypertension presents with increased difficulty breathing during exertion, swelling in the lower extremities, and fatigue. Physical examination reveals pitting edema and jugular venous distention. An echocardiogram shows mild left ventricular hypertrophy and reduced ejection fraction, and BNP level is elevated. Which intervention should the nurse prioritize to address the patient's condition?

B) Initiate dietary counseling to reduce sodium intake

A) Educate the patient on high-impact exercises to improve cardiovascular health

B) Initiate dietary counseling to reduce sodium intake

C) Encourage increased fluid intake to improve hydration

D) Recommend the patient reduce antihypertensive medication to prevent hypotension

A patient with rheumatoid arthritis and poorly controlled hypertension presents with symptoms suggesting heart failure. Which nursing intervention is most critical to prioritize in managing this patient’s current condition?

C) Administering the prescribed ACE inhibitor to improve cardiac function

A) Educating the patient about low-impact exercises to improve cardiovascular health

B) Encouraging immediate weight loss to reduce overall cardiac workload

C) Administering the prescribed ACE inhibitor to improve cardiac function

D) Scheduling frequent blood pressure monitoring to evaluate hypertension control

A patient with heart failure and hypertension has recently started an ACE inhibitor. At follow-up, the patient shows slight improvement in symptoms but reports persistent fatigue and ankle swelling. The nurse notes jugular venous distention and an increase in serum creatinine levels. Which nursing intervention is the most appropriate to address the patient's current condition?

B) Educate the patient about the importance of a low-sodium diet to manage fluid retention.

A) Increase the dose of the ACE inhibitor to further reduce blood pressure.

B) Educate the patient about the importance of a low-sodium diet to manage fluid retention.

C) Recommend the addition of a diuretic to reduce fluid overload.

D) Advise the patient to limit physical activity to reduce fatigue.

A patient with a history of heart failure and hypertension reports ongoing symptoms of fatigue and persistent ankle swelling despite a recent modification in her treatment plan. Her lab results show a decrease in BNP levels and a slight increase in serum creatinine. Which nursing intervention is the most appropriate to address these findings?

B) Educate the patient on the importance of a low-sodium diet to manage fluid retention.

A) Encourage the patient to increase fluid intake to improve kidney function.

B) Educate the patient on the importance of a low-sodium diet to manage fluid retention.

C) Suggest the patient stop taking her ACE inhibitor temporarily to protect renal function.

D) Advise the patient to reduce physical activity to decrease cardiac workload.

A patient with a history of heart failure and hypertension is experiencing dizziness upon standing, palpitations, and mild dyspnea. Her lab results show hyperkalemia and worsening renal function. Which nursing intervention is most appropriate to address her current condition?

B) Educate the patient to avoid potassium-rich foods.

A) Encourage increased fluid intake to promote renal function.

B) Educate the patient to avoid potassium-rich foods.

C) Monitor for signs of hypokalemia, such as muscle cramps.

D) Discontinue all antihypertensive medications to prevent further renal impairment.

A patient with a history of hypertension and chronic kidney disease is experiencing increased episodes of dizziness, palpitations, and decreased urine output. Her lab results show elevated serum potassium and serum creatinine levels. The healthcare team switches her medication from an ACE inhibitor to an ARB. Which nursing action is most appropriate to prioritize in this scenario?

D) Advise the patient to report any signs of muscle weakness or arrhythmias immediately.

A) Educate the patient on the importance of staying hydrated to improve urine output.

B) Monitor the patient's blood pressure and heart rate closely to assess the effectiveness of the new medication.

C) Instruct the patient to increase her dietary intake of potassium-rich foods to counteract dizziness.

D) Advise the patient to report any signs of muscle weakness or arrhythmias immediately.

Rheumatoid arthriis - Nursing Case Study

Pathophysiology

• Primary mechanism: Autoimmune Response - In rheumatoid arthritis (RA), the immune system mistakenly attacks synovial tissues, leading to inflammation. This is initiated by the activation of T-cells and the production of autoantibodies like rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs).

• Secondary mechanism: Synovial Hyperplasia and Pannus Formation - Chronic inflammation causes synovial cell proliferation, forming an aggressive tissue called pannus. The pannus invades and erodes cartilage and bone, contributing to joint destruction and deformity.

• Key complication: Joint Deformity and Loss of Function - Persistent inflammation and joint damage lead to deformities, significantly impacting mobility and quality of life. Early diagnosis and treatment are crucial to slow disease progression and manage symptoms.

Patient Profile

Demographics:

45-year-old female, office manager

History:

• Key past medical history: Diagnosed with rheumatoid arthritis 5 years ago; history of hypertension

• Current medications: Methotrexate, Prednisone, Lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing joint pain and stiffness

• Key symptoms: Morning stiffness lasting more than an hour, swelling in wrists and knees, fatigue, low-grade fever

• Vital signs: Blood pressure 150/95 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 99.1°F

Section 1

As the office manager presented for her follow-up appointment, the nurse conducted a thorough initial assessment. The patient reported that her joint pain and stiffness had progressively worsened over the past few weeks, and she was experiencing difficulties with everyday tasks such as typing and climbing stairs. On physical examination, there was notable swelling and tenderness in the wrists and knees, with reduced range of motion in both areas. Her morning stiffness persisted for more than 90 minutes each day, and she was visibly fatigued with a slight pallor. Her blood pressure remained elevated at 152/98 mmHg, and her heart rate was slightly tachycardic at 96 bpm, raising concerns about her cardiovascular status in the context of rheumatoid arthritis and chronic hypertension.

The nurse also observed that the patient's low-grade fever persisted, suggesting ongoing inflammation. To further evaluate her condition, a complete blood count (CBC) and C-reactive protein (CRP) test were ordered. The results revealed anemia with a hemoglobin level of 10.5 g/dL and an elevated CRP of 28 mg/L, indicating active inflammation and a possible flare of her rheumatoid arthritis. These findings, coupled with her increased joint pain and stiffness, suggested that her current treatment regimen might not be adequately controlling her disease activity.

Given the worsening of her symptoms and the laboratory findings, the healthcare team decided to adjust her treatment plan. The possibility of adding or switching to a biologic disease-modifying antirheumatic drug (DMARD) was discussed to better manage her symptoms and control the disease progression. The patient was also counseled on lifestyle modifications, including stress management and gentle physical activity, to improve her overall quality of life. The team planned to closely monitor her response to these changes and reassess her condition in several weeks, with the aim of preventing further joint damage and improving her functional status.

Section 2

Several weeks after her treatment plan was adjusted, the patient returned for a follow-up appointment. The nurse conducted a comprehensive assessment to evaluate her response to the new interventions. The patient reported a slight improvement in her joint pain and morning stiffness, which now lasted about 60 minutes compared to the previous 90 minutes. However, she continued to experience significant fatigue and had difficulty with prolonged physical activity, such as walking or standing for extended periods. On examination, there was a noticeable reduction in swelling and tenderness in her wrists, but her knees remained swollen and painful, with a limited range of motion.

Vital signs revealed a blood pressure of 148/95 mmHg and a heart rate of 92 bpm, indicating persistent hypertension and mild tachycardia. A follow-up CBC showed a slight improvement in hemoglobin levels to 11.0 g/dL, yet she remained anemic. The CRP level decreased to 20 mg/L, suggesting a reduction in systemic inflammation, but still above normal limits. These findings indicated partial improvement but highlighted the need for continued monitoring and possible further treatment adjustments. The healthcare team considered optimizing her biologic DMARD dosage and incorporating additional therapies to better manage her anemia and cardiovascular risk.

In addressing these concerns, the nurse also emphasized the importance of medication adherence and regular follow-up appointments. She reinforced lifestyle modifications, encouraging the patient to engage in low-impact exercises and consider dietary changes to address her anemia. The patient was educated on monitoring her symptoms and was advised to contact the healthcare team if she experienced any new or worsening symptoms, especially given the potential for cardiovascular complications associated with her condition. The plan was to reassess her clinical status in a month, aiming to achieve better symptom control and prevent further joint damage.

Section 3

Several weeks later, the patient returned for another follow-up appointment, presenting with new concerns. She reported increased difficulty with breathing during moderate exertion and noted a distinct swelling in her lower extremities, especially around the ankles, which she had not experienced before. The fatigue persisted, and she described it as more debilitating than during her previous visit. On physical examination, the nurse observed pitting edema in both ankles and mild jugular venous distention. These symptoms raised concerns about potential cardiac involvement, possibly exacerbated by her chronic inflammatory state and persistent hypertension.

Vital signs revealed a blood pressure of 160/100 mmHg and a heart rate of 98 bpm, showing worsening hypertension and increased tachycardia. Given these findings, the healthcare team ordered an echocardiogram and a BNP test to assess for possible heart failure. The echocardiogram showed mild left ventricular hypertrophy and reduced ejection fraction, suggesting early signs of heart failure. The BNP level was elevated at 450 pg/mL, confirming the suspicion of cardiac strain. It became evident that the patient's cardiovascular system was under significant stress, likely due to a combination of rheumatoid arthritis-related inflammation and poorly controlled blood pressure.

In response to these developments, the healthcare team decided to adjust her antihypertensive regimen, adding an ACE inhibitor to improve cardiac function and manage blood pressure more effectively. They also recommended a referral to a cardiologist for further evaluation and management. The nurse emphasized the importance of lifestyle modifications, including dietary changes to reduce sodium intake, continued low-impact exercises tailored to her current capabilities, and more frequent monitoring of her cardiovascular status. The plan involved close follow-up and reassessment in two weeks to evaluate the effectiveness of these interventions and prevent further deterioration of her cardiac health.

Section 4

Two weeks later, the patient returned for her follow-up appointment, eager to report on her progress since the adjustment in her treatment plan. She mentioned a slight improvement in her breathing during moderate exertion, yet she still experienced significant fatigue. Additionally, the swelling in her ankles persisted, albeit with less severity than before. Despite adherence to her new medication regimen and lifestyle modifications, she expressed concern about her ongoing symptoms. Upon physical examination, the nurse noted a mild reduction in the pitting edema but observed persistent jugular venous distention. Her vital signs showed a blood pressure of 150/95 mmHg and a heart rate of 92 bpm, indicating a slight improvement but still above the target range.

Laboratory tests were repeated to further assess her condition. The patient's BNP levels had decreased to 380 pg/mL, suggesting a modest reduction in cardiac strain. However, her renal function tests revealed a slight increase in serum creatinine levels at 1.3 mg/dL, raising concerns about potential renal impairment. This finding prompted the healthcare team to consider the impact of her newly added ACE inhibitor, known to affect renal function, and necessitated a careful evaluation of her current medication dosages.

Confronted with these mixed results, the healthcare team decided to continue the current antihypertensive regimen while closely monitoring her renal function. They emphasized the importance of maintaining adherence to her low-sodium diet and exercise routine. The patient was educated on recognizing signs of worsening heart failure and renal issues, such as increased swelling or changes in urinary output, and instructed to report any such changes promptly. A follow-up appointment was scheduled in four weeks, with interim phone check-ins to ensure close monitoring and timely intervention if needed.

Section 5

Four weeks later, the patient returned for her scheduled follow-up appointment, expressing gratitude for the interim phone support but voicing concern over new symptoms she had recently developed. She reported experiencing more frequent episodes of dizziness upon standing and occasional palpitations. Additionally, she noted a decrease in her urine output and a new onset of mild dyspnea at rest, which was particularly concerning to her. Despite these issues, she continued to adhere to her low-sodium diet and medication regimen as instructed.

During the physical examination, the nurse observed that while the pitting edema in the patient's ankles had slightly increased, the jugular venous distention remained unchanged. Her blood pressure was recorded at 142/90 mmHg, and her heart rate had increased to 98 bpm, indicating a subtle upward trend. Given the recent symptoms, the healthcare team decided to conduct further diagnostic tests, including a repeat echocardiogram and additional blood work to assess cardiac function and electrolyte balance. The laboratory results revealed an elevated serum potassium level at 5.5 mEq/L, raising concerns about hyperkalemia, likely exacerbated by her ACE inhibitor therapy. Her renal function showed further deterioration, with a serum creatinine level now at 1.5 mg/dL.

Faced with these developments, the healthcare team recognized the need to adjust her treatment plan to address the hyperkalemia and potential worsening of renal function. They decided to switch her from the ACE inhibitor to an angiotensin II receptor blocker (ARB) to mitigate the risk of further renal impairment while still managing her hypertension. The patient was educated on the importance of monitoring for signs of hyperkalemia, such as muscle weakness or arrhythmias, and was advised to avoid potassium-rich foods. A follow-up appointment was scheduled in two weeks to closely monitor her response to the medication adjustment and ensure stabilization of her renal function and electrolyte levels.